Pengyang Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pengyang Li has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Bo Wang
Department of Computer Science, University of Toronto, Toronto, Canada
1 shared publication - David J. Gonzalez
Department of Pharmacology, University of California San Diego, La Jolla, CA, USA
1 shared publication - John D. Lapek
Pfizer, Oncology Research & Development, San Diego, California
1 shared publication - Liangfang Zhang
University of California San Diego
1 shared publication - Ronnie H. Fang
Aiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San Diego, La Jolla, USA
1 shared publication - Xiaoli Wei
Department of Pharmacology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, PR China
1 shared publication
Latest Publications
- 20 September 2017
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 11 (12) , 11831-11838
Biomimetic Virulomics for Capture and Identification of Cell-Type Specific Effector Proteins
An unmet challenge in the study of disease is to accurately streamline the identification of important virulence factors. Traditional, genetically driven approaches miss biologically relevant markers due to discordance between the genome and proteome. Here, we developed a nanotechnology-enabled affinity enrichment strategy coupled with multiplexed quantitative proteomics, namely Biomimetic Virulomics, for successful identification of cell-type specific effector proteins of both prokaryotic and eukaryotic pathogens. We highlight the power of Biomimetic Virulomics by capturing known virulence factors in a high-throughput, cell-type guided fashion. Additionally, a comprehensive characterization of the membrane protein component of biomimetics utilized in this strategy is provided. Interfacing cell-derived nanomaterials with multiplexed quantitative proteomics allow for a specific targeting strategy of virulence factors that can be utilized for drug discovery against prominent human diseases.
- 20 September 2017
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 11 (12) , 11831-11838
Biomimetic Virulomics for Capture and Identification of Cell-Type Specific Effector Proteins
An unmet challenge in the study of disease is to accurately streamline the identification of important virulence factors. Traditional, genetically driven approaches miss biologically relevant markers due to discordance between the genome and proteome. Here, we developed a nanotechnology-enabled affinity enrichment strategy coupled with multiplexed quantitative proteomics, namely Biomimetic Virulomics, for successful identification of cell-type specific effector proteins of both prokaryotic and eukaryotic pathogens. We highlight the power of Biomimetic Virulomics by capturing known virulence factors in a high-throughput, cell-type guided fashion. Additionally, a comprehensive characterization of the membrane protein component of biomimetics utilized in this strategy is provided. Interfacing cell-derived nanomaterials with multiplexed quantitative proteomics allow for a specific targeting strategy of virulence factors that can be utilized for drug discovery against prominent human diseases.